Next Article in Journal
Proteome Analysis of Dormancy-Released Seeds of Fraxinus mandshurica Rupr. in Response to Re-Dehydration under Different Conditions
Next Article in Special Issue
Cancer Stratification by Molecular Imaging
Previous Article in Journal
The Anti-TNF-α Antibody Infliximab Inhibits the Expression of Fat-Transporter-Protein FAT/CD36 in a Selective Hepatic-Radiation Mouse Model
Previous Article in Special Issue
Expression and Diagnostic Value of HE4 in Pancreatic Adenocarcinoma
Open AccessArticle

Knockdown of UbcH10 Enhances the Chemosensitivity of Dual Drug Resistant Breast Cancer Cells to Epirubicin and Docetaxel

1
Department of Breast Surgery, Central Hospital of Huangpu District, Shanghai 20002, China
2
Department of Pathology, Central Hospital of Huangpu District, Shanghai 20002, China
3
Department of Respiratory Disease, Eastern Hepatobiliary Surgery Hospital, Secondary Military Medical University, Shanghai 200433, China
*
Authors to whom correspondence should be addressed.
Academic Editor: William Chi-Shing Cho
Int. J. Mol. Sci. 2015, 16(3), 4698-4712; https://doi.org/10.3390/ijms16034698
Received: 15 October 2014 / Revised: 5 February 2015 / Accepted: 13 February 2015 / Published: 2 March 2015
Breast cancer is one of the most common and lethal cancers in women. As a hub gene involved in a diversity of tumors, the ubiquitin-conjugating enzyme H10 (UbcH10), may also play some roles in the genesis and development of breast cancer. In the current study, we found that the expression of UbcH10 was up-regulated in some breast cancer tissues and five cell lines. We established a dual drug resistant cell line MCF-7/EPB (epirubicin)/TXT (docetaxel) and a lentiviral system expressing UbcH10 shRNA to investigate the effects of UbcH10 knockdown on the chemosensitivity of MCF-7/EPB/TXT cells to epirubicin and docetaxel. The knockdown of UbcH10 inhibited the proliferation of both MCF-7 and MCF-7/EPB/TXT cells, due to the G1 phase arrest in cell cycle. Furthermore, UbcH10 knockdown increased the sensitivity of MCF-7/EPB/TXT cells to epirubicin and docetaxel and promoted the apoptosis induced by these two drugs. Protein detection showed that, in addition to inhibiting the expression of Ki67 and cyclin D1, UbcH10 RNAi also impaired the increased BCL-2 and MDR-1 expression levels in MCF-7/EPB/TXT cells, which may contribute to abating the drug resistance in the breast cancer cells. Our research in the current study demonstrated that up-regulation of UbcH10 was involved in breast cancer and its knockdown can inhibit the growth of cancer cells and increase the chemosensitivity of the dual drug resistant breast cancer cells to epirubicin and docetaxel, suggesting that UbcH10 may be a promising target for the therapy of breast cancer. View Full-Text
Keywords: UbcH10; chemosensitivity; breast cancer; gene knockdown UbcH10; chemosensitivity; breast cancer; gene knockdown
Show Figures

Figure 1

MDPI and ACS Style

Wang, C.; Pan, Y.-H.; Shan, M.; Xu, M.; Bao, J.-L.; Zhao, L.-M. Knockdown of UbcH10 Enhances the Chemosensitivity of Dual Drug Resistant Breast Cancer Cells to Epirubicin and Docetaxel. Int. J. Mol. Sci. 2015, 16, 4698-4712.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop